Pan-cancer analysis and experimental verification of its roles and clinical significance of SLC2A3 in kidney renal clear cell carcinoma
Collectively, our data imply that SLC2A3 serves as an oncogenic driver in multiple cancers, contributing to KIRC progression via the enhancement of pro-tumorigenic pathways.
Authors
- Guangsuo Wang
- Qingshan Yang (ORCID: https://orcid.org/0000-0001-9277-0026)
- Haichao Yuan (ORCID: https://orcid.org/0000-0002-7299-779X)
- Zhaojie Lyu (ORCID: https://orcid.org/0000-0001-6357-9505)
- Liangkuan Bi (ORCID: https://orcid.org/0000-0002-5070-778X)
- Zhengping Zhao
- Yang Yu (ORCID: https://orcid.org/0000-0001-6963-1669)
- Xueqi Zhang (ORCID: https://orcid.org/0000-0001-9325-9166)
Institutions
- Southern University of Science and Technology (CN)
- Peking University Shenzhen Hospital (CN)
- Shenzhen Second People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-11-05
- DOI
- https://doi.org/10.3389/fimmu.2025.1694137
- Primary Topic
- Genetic and Kidney Cyst Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00